REGENERON PHARMACEUTICALS, INC.

A biotech firm inventing, developing, and commercializing medicines for serious diseases.

REGN | US

Overview

Corporate Details

ISIN(s):: US75886F1075
LEI:
Country:: United States of America
Address:: 777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN
Website:: https://www.regeneron.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Founded in 1988, the company leverages its scientific and technological capabilities to produce a portfolio of treatments and a pipeline of product candidates. Its research and development efforts span multiple therapeutic areas, including ophthalmology, oncology, cardiovascular and metabolic diseases, and inflammatory conditions. Regeneron focuses on turning cutting-edge science into transformative medicines, with active programs in areas such as genetic medicines (including CRISPR), cancer-fighting immunotherapies, and treatments for obesity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REGENERON PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REGENERON PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REGENERON PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CureVac N.V. Pioneering mRNA technology for prophylactic vaccines and novel cancer immunotherapies.	United States of America	CVAC
CURIS INC Biotech developing innovative cancer therapeutics for hematologic malignancies.	United States of America	CRIS
Curocell Inc. Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.	South Korea	372320
CYBIN INC. A clinical-stage firm engineering novel psychedelic drugs for depression and anxiety.	United States of America	CYBN
Cyclerion Therapeutics, Inc. Developing personalized therapy for TRD with a biofeedback device and anesthetics.	United States of America	CYCN
Cyfuse Biomedical K.K.	Japan	4892
CYTOKINETICS INC Late-stage biopharma developing muscle-modulating drugs for heart and neuromuscular diseases.	United States of America	CYTK
CytoMed Therapeutics Ltd Develops off-the-shelf cell immunotherapies using γδ T cells & NK cells for cancer treatment.	United States of America	GDTC
CytomX Therapeutics, Inc. Develops tumor-activated antibody therapeutics for more targeted, less toxic cancer treatments.	United States of America	CTMX
Daebonglsco.,Ltd Develops raw materials and APIs for the personal care, pharmaceutical, and food industries.	South Korea	078140